Spots Global Cancer Trial Database for A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
Official Title: A Phase II Multicenter, Parallel Group, Randomized Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Subjects With Unresectable or Metastatic Soft-tissue Sarcoma
Study ID: NCT00718484
Conditions
Study Description
Brief Summary: This is a randomized, controlled trial to evaluate the clinical benefit of palifosfamide tris administered with doxorubicin in combination, compared with single-agent doxorubicin administered in subjects diagnosed with unresectable or metastatic soft-tissue sarcoma (STS). Subjects who meet the entry criteria will be randomized into 1 of 2 arms: either to receive palifosfamide tris plus doxorubicin or treatment with single-agent doxorubicin. Subjects will be anthracyclin naïve.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Santa Monica, California, United States
, Washington, District of Columbia, United States
, Tampa, Florida, United States
, Coeur d'Alene, Idaho, United States
, Chicago, Illinois, United States
, Park Ridge, Illinois, United States
, Iowa city, Iowa, United States
, Lenaxa, Kansas, United States
, Albuquerque, New Mexico, United States
, New York, New York, United States
, Durham, North Carolina, United States
, Portland, Oregon, United States
, Philadelphia, Pennsylvania, United States
, Memphis, Tennessee, United States
, Nashville, Tennessee, United States
, San Antonio, Texas, United States
, Salt Lake City, Utah, United States
, Seattle, Washington, United States
, Milan, , Italy
, Padova, , Italy
, Torino, , Italy
, Cluj-Napoca, , Romania
, Lasi, , Romania
Contact Details
Name: Jonathan J Lewis, MD, PhD
Affiliation: ZIOPHARM Oncology, Inc
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
